Icandra kombinerer to antihyperglykæmiske midler med komplementære virkningsmekanismer for at forbedre den glykæmiske kontrol hos patienter med type 2- diabetes: vildagliptin, der tilhører klassen af ø- celle- forstærkere, og metformin- hydrochlorid, der tilhører klassen af biguanider.
Icandra combines two antihyperglycaemic agents with complimentary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: vildagliptin, a member of the islet enhancer class, and metformin hydrochloride, a member of the biguanide class.